Journal of Pharmaceutical Policy and Practice

Clinical pharmacy has undergone significant transformation in recent years from a product-focused discipline to a patient-centered, driven by technological advancements and a growing emphasis on optimizing medication therapy and improving health outcomes. The integration of artificial intelligence (AI) and machine learning algorithms has also the growing emphasis on personalized therapy present key challenges in diverse healthcare systems. New technologies, precision medicine, and data-driven clinical decision support systems are changing how pharmacists contribute within multidisciplinary teams. The expansion of pharmacists’ roles in chronic disease management, antimicrobial stewardship, and personalized care reflects a commitment to integrating evidence-based practice into clinical settings. Advancements in pharmacogenomics, tele pharmacy, and AI-enabled tools further enhance pharmacists’ capacity to deliver safe, effective, and efficient care.

This article collection, which welcomes research presented at the 24th Asian Conference on Clinical Pharmacy (The 24th ACCP) July 24 - 27 2025, seeks to capture these developments, highlighting research, policy analyses, and innovative practices that shape the future of clinical pharmacy and its impact on healthcare systems worldwide.

The advancement of clinical pharmacy is critical in addressing global healthcare challenges, including medication safety, rising healthcare costs, and increasing demands for patient-centered care. Pharmacists possess a unique skill set for managing complex medication regimens, reducing adverse drug events, and enhancing therapeutic outcomes. As healthcare systems strive for efficiency and safety, clinical pharmacy innovation, such as remote consultations, real-time monitoring, and integration of big data, offer transformative solutions. Policymakers and practitioners must understand how these advancements align with health system reforms, WHO medication safety initiatives, and sustainable universal health coverage. Publishing and disseminating evidence on effective clinical pharmacy innovations can inform policy, foster international collaboration, and ensure equitable access to high-quality pharmaceutical care. Continuous development in this field supports evidence-based practice, enhances access to care, and ensures that pharmacy remains a cornerstone of safe, effective, and patient-centered healthcare.

This collection fits the Journal of Pharmaceutical Policy and Practice Scope, which prioritizes health policy, practice models, and service innovations in pharmacy.

Suggested subtopics include:

Pharmacist-lead interventions in chronic disease and polypharmacy management

Digital health and tele pharmacy applications in clinical services

Pharmacogenomics and precision medicine integration into care pathways

Medication safety strategies and high-alert / LASA drug management

Interprofessional collaboration models for optimising patient outcomes

Policy analysis of pharmacist scope of practice and reimbursement models

Keywords:

• clinical pharmacy
• telepharmacy
• patient-centered care
• interprofessional collaboration
• pharmaceutical innovation

All manuscripts submitted to this Article Collection will undergo desk assessment and peer review if they can pass the desk assessments as part of our standard editorial process; the Guest Advisor for this Collection will not be handling the manuscripts (unless they are an Editorial Board member).

The deadline for submitting manuscripts is 31 July 2026.